Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Chinese Registry to Determine the Serumal Biomarkers for Prognosis of Adverse Events in Patients Undergoing Coronary Artery Bypass Grafting.

NCT04107571 is registered in ClinicalTrials.gov with Beijing Institute of Heart, Lung and Blood Vessel Diseases as lead sponsor.

NCT NCT04107571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04107571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Chinese Registry to Determine the Serumal Biomarkers for Prognosis of Adverse Events in Patients Undergoing Coronary Artery Bypass Grafting.
Lead sponsor
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2019
Completion date
June 30, 2024
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac surgery